Anifrolumab as Rescue Therapy in Life-Threatening, Infection-Complicated SLE: A Biomarker-Guided Case Beyond Trial Criteria

    March 2026
    C.I. Baldwin, James Galloway, Patrick Gordon, Chris Wincup
    Studysummary This case report describes how anifrolumab, used beyond trial-eligible populations, led to significant clinical and serological recovery in a 45-year-old woman with organ-threatening systemic lupus erythematosus complicated by infection and resistant to conventional treatments like cyclophosphamide and rituximab.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →